Proanthocyanidin-Conjugated NIR-ΙΙ Nano-Prodrugs for Reversing Drug Resistance in Photothermal Therapy
Molecules · 2025
DOI: 10.3390/molecules30112334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Lan Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Proanthocyanidins, Prodrugs, Drug Resistance, Neoplasm, Doxorubicin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High-Level Talent Research Start-up Fund Project of Henan University of Technology, Science and Technology Research Project of Henan Province, Innovative Funds Plan of Henan University of Technology in Henan Province.
Abstract (Originalsprache)
Targeting and multidrug resistance are the significant problems of current antitumor drugs, and these problems become the key factors in the design of nanomedicine. Herein, Au NRs and OPC-Au NPs were prepared via the hydroquinone seedless growth method and proanthocyanidin (OPC) one-pot method, and then pH-GSH-near-infrared ΙΙ (NIR-ΙΙ)-responsive nano-prodrugs Au/DOX-ss LNRs and OPC-Au/DOX-ss LNPs were designed by the encapsulation of doxorubicin prodrug DOX-ss with Au-S affinity and thermal-sensitive liposomes. Interestingly, OPC endowed OPC-Au NPs with reducibility and excellent performance in terms of particle size, zeta potential, encapsulation rate, and drug loading rate. In particular, the photothermal efficiencies of OPC-Au/DOX-ss LNPs increased to 59.22% under the 1064 nm NIR-ΙΙ irradiation. Compared with free DOX-ss and Lipid DOX-ss, the IC50 of OPC-Au/DOX-ss LNPs was decreased by 91.68% and 97.60%, respectively. Furthermore, the expression of P-gp in MCF-7/ADR was significantly inhibited (decreased by 65%). The potential of proanthocyanidin remodels the pH-GSH-NIR-ΙΙ responsiveness and drug resistance of OPC-Au/DOX-ss LNPs for breast cancer treatment in NIR-ΙΙ photodynamic/photothermal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
- Institute for Complexity Science, Henan University of Technology, Zhengzhou 450001, China.
- College of Chemistry, Zhengzhou University, Zhengzhou 450001, China.
ORCID-Profile: Shuoye Yang, Guangzhou Zhou, Peng Li
Förderung
- High-Level Talent Research Start-up Fund Project of Henan University of Technology
- Science and Technology Research Project of Henan Province
- Innovative Funds Plan of Henan University of Technology in Henan Province
- Major Science and Technology Special Projects in Henan Province
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Cui, L., Lou, W., Wei, X., Li, M., Sun, M., Wang, S., Yang, S., Zhang, L., Zhou, G., Li, P., & Qu, L. (2025). Proanthocyanidin-Conjugated NIR-ΙΙ Nano-Prodrugs for Reversing Drug Resistance in Photothermal Therapy. Molecules. https://doi.org/10.3390/molecules30112334
Vancouver
Cui L, Lou W, Wei X, Li M, Sun M, Wang S, et al. Proanthocyanidin-Conjugated NIR-ΙΙ Nano-Prodrugs for Reversing Drug Resistance in Photothermal Therapy. Molecules. 2025. doi:10.3390/molecules30112334
BibTeX
@article{Cui2025,
author = {Cui, Lan and Lou, Weishuang and Wei, Xin and Li, Mengdi and Sun, Mengyao and Wang, Siyue and Yang, Shuoye and Zhang, Lu and Zhou, Guangzhou and Li, Peng and Qu, Lingbo},
title = {Proanthocyanidin-Conjugated NIR-ΙΙ Nano-Prodrugs for Reversing Drug Resistance in Photothermal Therapy},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112334}
}
EUVIMED